(Total Views: 451)
Posted On: 12/16/2024 11:56:28 AM
Post# of 148863
May 30, 2024
Near the end of the May 2024 investor update call it was mentioned that, the preclinical study of leronlimab in glioblastoma at Einstein Montefiore in New York, was underway after some unavoidable delays and that they look forward to reviewing those results by the end of the year. Here is the link to the call.
https://www.cytodyn.com/newsroom/press-releas...any-update
someone posted a transcript at
https://www.reddit.com/r/Livimmune/comments/1...4_webcast/
Sept 9, 2024
"the results from the preclinical Glioblastoma study in mice performed by the Albert Einstein College of Medicine should be released in the coming months."
https://www.cytodyn.com/newsroom/press-releas...areholders
Near the end of the May 2024 investor update call it was mentioned that, the preclinical study of leronlimab in glioblastoma at Einstein Montefiore in New York, was underway after some unavoidable delays and that they look forward to reviewing those results by the end of the year. Here is the link to the call.
https://www.cytodyn.com/newsroom/press-releas...any-update
someone posted a transcript at
https://www.reddit.com/r/Livimmune/comments/1...4_webcast/
Sept 9, 2024
"the results from the preclinical Glioblastoma study in mice performed by the Albert Einstein College of Medicine should be released in the coming months."
https://www.cytodyn.com/newsroom/press-releas...areholders
(11)
(0)
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
Scroll down for more posts ▼
